Company profile IGMS
After 34 days of this quarter the interest is at 126.0. Based on that we can calculate that during remaining 58 days it will total up to 341.0. IGM Biosciences stock expected interest is significantly higher compared to previous quarter (+136.8%) and same quarter last year (+693.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 58 |
| 2019 | 94 62.1% QoQ | 199 111.7% QoQ | 112 -43.7% QoQ | 69 19.0% YoY -38.4% QoQ |
| 2020 | 133 41.5% YoY 92.8% QoQ | 45 -77.4% YoY -66.2% QoQ | 117 4.5% YoY 160.0% QoQ | 142 105.8% YoY 21.4% QoQ |
| 2021 | 238 78.9% YoY 67.6% QoQ | 72 60.0% YoY -69.7% QoQ | 77 -34.2% YoY 6.9% QoQ | 189 33.1% YoY 145.5% QoQ |
| 2022 | 182 -23.5% YoY -3.7% QoQ | 211 193.1% YoY 15.9% QoQ | 190 146.8% YoY -10.0% QoQ | 43 -77.2% YoY -77.4% QoQ |
| 2023 | 60 -67.0% YoY 39.5% QoQ | 162 -23.2% YoY 170.0% QoQ | 144 -24.2% YoY -11.1% QoQ | 126 193.0% YoY -12.5% QoQ |
The average 5 years interest of IGM Biosciences stock was 10.24 per week. The last year interest of IGM Biosciences stock compared to the last 5 years has changed by -7.62%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by -7.53%.
After 39 days of this quarter the interest is at 31.0. Based on that we can calculate that during remaining 52 days it will total up to 72.0. IGM Biosciences news expected interest is significantly higher compared to previous quarter (+75.6%) but similar to same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 90 | 246 173.3% QoQ | 67 -72.8% QoQ | 37 -44.8% QoQ |
| 2020 | 81 -10.0% YoY 118.9% QoQ | 47 -80.9% YoY -42.0% QoQ | 59 -11.9% YoY 25.5% QoQ | 100 170.3% YoY 69.5% QoQ |
| 2021 | 55 -32.1% YoY -45.0% QoQ | 224 376.6% YoY 307.3% QoQ | 22 -62.7% YoY -90.2% QoQ | 68 -32.0% YoY 209.1% QoQ |
| 2022 | 25 -54.5% YoY -63.2% QoQ | 133 -40.6% YoY 432.0% QoQ | 154 600.0% YoY 15.8% QoQ | 99 45.6% YoY -35.7% QoQ |
| 2023 | 86 244.0% YoY -13.1% QoQ | 146 9.8% YoY 69.8% QoQ | 89 -42.2% YoY -39.0% QoQ | 41 -58.6% YoY -53.9% QoQ |
| 2024 | 31 -64.0% YoY -24.4% QoQ | - | - | - |
The average 5 years interest of IGM Biosciences news was 7.28 per week. The last year interest of IGM Biosciences news compared to the last 5 years has changed by -18.96%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -30.26%.
There is not enough data for IGM Biosciences immunoglobulin M antibodies to provide analysis
There is not enough data for IGM Biosciences immunoglobulin M antibodies to provide correlation calculation
There is not enough data for IGM Biosciences immunoglobulin M antibodies to provide analysis
There is not enough data for IGM Biosciences clinical-stage biotechnology to provide analysis
There is not enough data for IGM Biosciences clinical-stage biotechnology to provide correlation calculation
There is not enough data for IGM Biosciences clinical-stage biotechnology to provide analysis
There is not enough data for IGM Biosciences CD20 x CD3 bispecific antibody to provide analysis
There is not enough data for IGM Biosciences CD20 x CD3 bispecific antibody to provide correlation calculation
There is not enough data for IGM Biosciences CD20 x CD3 bispecific antibody to provide analysis
Google Trends for IGM Biosciences Phase 2 clinical trials
Not enough data for reliable calculations!
There is not enough data for IGM Biosciences Phase 2 clinical trials to provide analysis
There is not enough data for IGM Biosciences Phase 2 clinical trials to provide correlation calculation
There is not enough data for IGM Biosciences Phase 2 clinical trials to provide analysis
There is not enough data for IGM Biosciences B cell non-Hodgkin's lymphoma to provide analysis
There is not enough data for IGM Biosciences B cell non-Hodgkin's lymphoma to provide correlation calculation
There is not enough data for IGM Biosciences B cell non-Hodgkin's lymphoma to provide analysis
There is not enough data for IGM Biosciences solid cancers to provide analysis
There is not enough data for IGM Biosciences solid cancers to provide correlation calculation
There is not enough data for IGM Biosciences solid cancers to provide analysis
There is not enough data for IGM Biosciences anti-PD-L1 antibody to provide analysis
There is not enough data for IGM Biosciences anti-PD-L1 antibody to provide correlation calculation
There is not enough data for IGM Biosciences anti-PD-L1 antibody to provide analysis
There is not enough data for IGM Biosciences multiple myeloma to provide analysis
There is not enough data for IGM Biosciences multiple myeloma to provide correlation calculation
There is not enough data for IGM Biosciences multiple myeloma to provide analysis